ArticleBiomedicines2023

Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer.

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.